From theheart.org on Medscape

News from the

Transcatheter Cardiovascular Therapeutics (TCT) 2015

October 11 - 15, 2015; San Francisco, California

Visit Medscape at Booth #2306

Meeting Highlights at a Glance

Top News From TCT 2015: Slideshow This year's conference featured new data on bioresorbable stents, thrombus aspiration in STEMI, transcatheter aortic-valve replacement (TAVR), and more.

Conference News

TCT Even at 2 Years, Drug-Coated Bests Standard Balloon in SFA
Heartwire from Medscape, October 27, 2015
TCT Deferring Stent After Infarct-Artery Opening May Limit MI Size
Heartwire from Medscape, October 23, 2015
TCT RIVER-PCI: No Benefit of Ranolazine After Incomplete Revascularization
Heartwire from Medscape, October 20, 2015
TCT Surgery Improves Outcomes in Asymptomatic Aortic Stenosis
Heartwire from Medscape, October 20, 2015
TCT PARTNER II Backs Valve-in-Valve TAVR in Failed Prosthetic Valves
Heartwire from Medscape, October 19, 2015
TCT Experts Debate Risk of Thrombosis With Bioprosthetic Valves
Heartwire from Medscape, October 19, 2015
TCT RESPECT at 10 Years Supports Case for PFO Closure for Stroke
Heartwire from Medscape, October 16, 2015
TCT TUXEDO-India: Paclitaxel Stent Flops vs 'Limus' Even in Diabetics
Heartwire from Medscape, October 16, 2015
Alert TCT FDA Approves Sapien XT for Valve-in-Valve TAVR
FDA Approvals, October 15, 2015
TCT BRAVO 3: Bivalirudin No Better Than Heparin in TAVR
Heartwire from Medscape, October 15, 2015

TCT Sirolimus Stent Differences From Elution Kinetics, Says PANDA
Heartwire from Medscape, October 15, 2015
TCT Polymer-Free Stent Superior to BMS in High-Risk Patients
Heartwire from Medscape, October 14, 2015
TCT DAPT Results Confirmed in Trial's Everolimus-Stent Patients
Heartwire from Medscape, October 14, 2015
TCT Trial Questions Staged Chronic-Occlusion PCI After Primary PCI
Heartwire from Medscape, October 14, 2015
TCT Use of FFR-CT Reduces Costs Compared With Diagnostic Angiography
Heartwire from Medscape, October 14, 2015
TCT No Benefit for Thrombus Aspiration in STEMI Patients
Heartwire from Medscape, October 13, 2015
TCT DRAGON: Radial PCI Noninferior to Femoral, With Less Bleeding
Heartwire from Medscape, October 13, 2015
TCT Metal May Rival 'Plastic' for Disappearing Stents: BIOSOLVE II
Heartwire from Medscape, October 13, 2015
TCT ABSORB III and More: Bioresorbable Stent Noninferior to Xience
Heartwire from Medscape, October 13, 2015
TCT TCT 2015: Bioresorbable Stents, TAVR, and More
Heartwire from Medscape, October 5, 2015

Perspectives from TCT

Clinical Trial Enrollment: The United States Needs to Do Better
Ileana L. Piña, MD, MPH
FFR-CT Angiography: The PROMISE of PLATFORM
Robert A. Harrington, MD; Pamela S. Douglas, MD
TCT: Structural Heart Disease and PFO Closure Trials
Robert A. Harrington, MD; Deepak L. Bhatt, MD, MPH

Previous Coverage